Monoclonal antibodies
McKnight’s reported that new research shows real promise for treating COVID-19 with monoclonal antibodies. Many caregivers see antibodies as a way of mitigating COVID symptoms, preventing hospitalizations, and premature deaths. Monoclonal antibodies finally received Emergency Use Authorization in late November. Just 20% of the available antibodies had been used. This miracle treatment is finally available
Recent Comments